Room: Track 3
Purpose:
We presented a novel tool of voxel-based dose-linear-energy-transfer (LET) volume histogram (DLVH) to present dose and LET information simultaneously in one plot. This tool was applied to patients experiencing adverse events in head and neck (H&N) cancer treated by intensity-modulated proton therapy (IMPT).
Methods:
Physical dose and LET distributions were calculated using Monte Carlo simulations. DLVH was constructed with physical dose (in Gy[RBE]) and LET (in keV/µm) as two horizontal axes. The normalized volume of the structure was contoured as iso-volume lines in the dose-LET plane. Similar to dose-volume histogram indices such as Dv%, these iso-volume lines, DLv%, indicated the percentage volume v of a structure that had a dose of at least d Gy[RBE] and an LET of at least l keV/µm. All voxels in the structure were mapped into the dose-LET plane as dots to see how the dots with similar dose and LET were clustered. We included 20 head and neck (H&N) patients with unexpected adverse events (CTCAE grade=2) for analysis. The adverse event sites were contoured by the treating physicians and the corresponding DLVHs of the adverse event sites were generated and quantified to derive the voxel-wise dose-LET relationship in the adverse event regions.
Results:
Nine types of adverse events were observed in 20 patients and 23 adverse event regions were contoured. DLVHs exhibited highly correlated patterns between dose and LET. Dose played a dominant role for in-target adverse events such as hemorrhage and ulceration, while LET played an important role in out-of-target adverse events such as osteoradionecrosis and mucositis.
Conclusion:
Our results suggest that dose and LET can contribute to adverse events in a combined and/or independent fashion. DLVH could be a powerful tool in predicting patient outcomes. Further study is underway to evaluate its use in plan evaluation to mitigate adverse events.
Funding Support, Disclosures, and Conflict of Interest: Supported by the National Cancer Institute Career Developmental Award K25-CA168984, by Arizona Biomedical Research Commission Investigator Award, by The Lawrence W. and Marilyn W. Matteson Fund for Cancer Research, and by The Kemper Marley Foundation.
Protons, LET, Dose Volume Histograms
TH- Radiobiology(RBio)/Biology(Bio): RBio- Particle therapy- Protons